192 related articles for article (PubMed ID: 33658340)
1. People with HIV-1 demonstrate type 1 interferon refractoriness associated with upregulated USP18.
Sugawara S; El-Diwany R; Cohen LK; Rousseau KE; Williams CYK; Veenhuis RT; Mehta SH; Blankson JN; Thomas DL; Cox AL; Balagopal A
J Virol; 2021 Apr; 95(10):. PubMed ID: 33658340
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
MacParland SA; Ma XZ; Chen L; Khattar R; Cherepanov V; Selzner M; Feld JJ; Selzner N; McGilvray ID
J Virol; 2016 Jun; 90(12):5549-5560. PubMed ID: 27009955
[TBL] [Abstract][Full Text] [Related]
3. Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection.
Randall G; Chen L; Panis M; Fischer AK; Lindenbach BD; Sun J; Heathcote J; Rice CM; Edwards AM; McGilvray ID
Gastroenterology; 2006 Nov; 131(5):1584-91. PubMed ID: 17101330
[TBL] [Abstract][Full Text] [Related]
4. Acetaldehyde Disrupts Interferon Alpha Signaling in Hepatitis C Virus-Infected Liver Cells by Up-Regulating USP18.
Ganesan M; Poluektova LY; Tuma DJ; Kharbanda KK; Osna NA
Alcohol Clin Exp Res; 2016 Nov; 40(11):2329-2338. PubMed ID: 27716962
[TBL] [Abstract][Full Text] [Related]
5. cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice.
Gruenbach M; Muller CKS; Schlaepfer E; Baroncini L; Russenberger D; Kadzioch NP; Escher B; Schlapschy M; Skerra A; Bredl S; Speck RF
J Virol; 2022 Nov; 96(21):e0082722. PubMed ID: 36250708
[TBL] [Abstract][Full Text] [Related]
6. Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon.
Akiyama H; Ramirez NP; Gibson G; Kline C; Watkins S; Ambrose Z; Gummuluru S
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794041
[TBL] [Abstract][Full Text] [Related]
7. Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4
Freitas IT; Tinago W; Sawa H; McAndrews J; Doak B; Prior-Fuller C; Sheehan G; Lambert JS; Muldoon E; Cotter AG; Hall WW; Mallon PWG; Carr MJ
AIDS Res Ther; 2020 Apr; 17(1):13. PubMed ID: 32295609
[TBL] [Abstract][Full Text] [Related]
8. USP18 is a significant driver of memory CD4 T-cell reduced viability caused by type I IFN signaling during primary HIV-1 infection.
Dagenais-Lussier X; Loucif H; Cadorel H; Blumberger J; Isnard S; Bego MG; Cohen ÉA; Routy JP; van Grevenynghe J;
PLoS Pathog; 2019 Oct; 15(10):e1008060. PubMed ID: 31658294
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages.
Taylor JP; Cash MN; Santostefano KE; Nakanishi M; Terada N; Wallet MA
J Leukoc Biol; 2018 Feb; 103(6):1225-40. PubMed ID: 29437254
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction.
Gargan S; Ahmed S; Mahony R; Bannan C; Napoletano S; O'Farrelly C; Borrow P; Bergin C; Stevenson NJ
EBioMedicine; 2018 Apr; 30():203-216. PubMed ID: 29580840
[TBL] [Abstract][Full Text] [Related]
11. A Low Frequency of IL-17-Producing CD8
Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
Front Immunol; 2018; 9():2502. PubMed ID: 30420859
[TBL] [Abstract][Full Text] [Related]
12. USP18 (UBP43) Abrogates p21-Mediated Inhibition of HIV-1.
Osei Kuffour E; Schott K; Jaguva Vasudevan AA; Holler J; Schulz WA; Lang PA; Lang KS; Kim B; Häussinger D; König R; Münk C
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068654
[TBL] [Abstract][Full Text] [Related]
13. Innate immune regulation in HIV latency models.
Olson RM; Gornalusse G; Whitmore LS; Newhouse D; Tisoncik-Go J; Smith E; Ochsenbauer C; Hladik F; Gale M
Retrovirology; 2022 Jul; 19(1):15. PubMed ID: 35804422
[TBL] [Abstract][Full Text] [Related]
14. USP18 Mediates Interferon Resistance of Dengue Virus Infection.
Ye H; Duan X; Yao M; Kang L; Li Y; Li S; Li B; Chen L
Front Microbiol; 2021; 12():682380. PubMed ID: 34017322
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of SOCS1 increases interferon-induced ISGylation during differentiation of induced-pluripotent stem cells to hepatocytes.
Edwards JS; Delabat SA; Badilla AD; DiCaprio RC; Hyun J; Burgess RA; Silva T; Dykxhoorn DM; Chen SX; Wang L; Ishida Y; Saito T; Thomas E
JHEP Rep; 2022 Dec; 4(12):100592. PubMed ID: 36439639
[TBL] [Abstract][Full Text] [Related]
16. ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53.
Osei Kuffour E; König R; Häussinger D; Schulz WA; Münk C
mBio; 2019 Aug; 10(4):. PubMed ID: 31455647
[TBL] [Abstract][Full Text] [Related]
17. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
Hensley KS; Jongkees MJ; Geers D; GeurtsvanKessel CH; Mueller YM; Dalm VASH; Papageorgiou G; Steggink H; Gorska A; Bogers S; den Hollander JG; Bierman WFW; Gelinck LBS; Schippers EF; Ammerlaan HSM; van der Valk M; van Vonderen MGA; Delsing CE; Gisolf EH; Bruns AHW; Lauw FN; Berrevoets MAH; Sigaloff KCE; Soetekouw R; Branger J; de Mast Q; Lammers AJJ; Lowe SH; de Vries RD; Katsikis PD; Rijnders BJA; Brinkman K; Roukens AHE; Rokx C
PLoS Med; 2022 Oct; 19(10):e1003979. PubMed ID: 36301821
[TBL] [Abstract][Full Text] [Related]
19. IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection.
Sung PS; Hong SH; Chung JH; Kim S; Park SH; Kim HM; Yoon SK; Shin EC
Sci Rep; 2017 Jun; 7(1):3821. PubMed ID: 28630501
[TBL] [Abstract][Full Text] [Related]
20. Distinct Type I Interferon Subtypes Differentially Stimulate T Cell Responses in HIV-1-Infected Individuals.
Karakoese Z; Schwerdtfeger M; Karsten CB; Esser S; Dittmer U; Sutter K
Front Immunol; 2022; 13():936918. PubMed ID: 35911692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
